All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for RECORDATI RARE DISEASES INC. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Medicare/Medicaid

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Health Issues

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Trade (domestic/foreign)

Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.